Performance of the Breast Cancer Risk Assessment Tool among Women Aged 75 Years and Older

Journal of the National Cancer Institute

Volumn 108, Issue 3, 2016, Pages

  Schonberg, Mara A ^a   Li, Vicky W ^a   Eliassen, A Heather ^b,c   Davis, Roger B ^a   Lacroix, Andrea Z ^d   McCarthy, Ellen P ^a   Rosner, Bernard A ^b,c   Chlebowski, Rowan T ^e   Rohan, Thomas E ^f   Hankinson, Susan E ^b,c,g   Marcantonio, Edward R ^a   Ngo, Long H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UCLA MEDICAL CENTER   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CANCER RISK ASSESSMENT TOOL; CALIBRATION; CANCER INCIDENCE; CANCER RISK; CONFIDENCE INTERVAL; ETHNICITY; FAMILY HISTORY; HUMAN; MAMMOGRAPHY; MENARCHE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; RISK FACTOR; AGE; BREAST NEOPLASMS; CAUCASIAN; CAUSE OF DEATH; EARLY CANCER DIAGNOSIS; EVALUATION STUDY; FEMALE; FOLLOW UP; INCIDENCE; MASS SCREENING; MIDDLE AGED; ODDS RATIO; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; UNITED STATES; VERY ELDERLY; WOMEN'S HEALTH;

AGE FACTORS; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CAUSE OF DEATH; EARLY DETECTION OF CANCER; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; MODELS, STATISTICAL; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 85014565173     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv348     Document Type: Article

References (31)

1. Data on Seer (Surveillance, Epidemiology and End Results) cancer statistics. http://seer.cancer.gov. Accessed on September 10, 2014.
2. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012;380(9855):1778-1786.
3. Breast cancer screening in older women. American Geriatrics Society Clinical Practice Committee. J Am Geriatr Soc. 2000;48(7):842-844.
4. Walter LC, Schonberg MA. Screening mammography in older women: a review. JAMA. 2014;311(13):1336-1347.
5. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK. Prognostic indices for older adults: a systematic review. JAMA. 2012;307(2):182-192.
6. Schonberg MA, Hamel MB, Davis RB, et al. Development and evaluation of a decision aid on mammography screening for women 75 years and older. JAMA Intern Med. 2014;174(3):417-424.
7. Breast Cancer Risk Assessment SAS Macro (Gail Model). http://dceg.cancer. gov/tools/risk-assessment/bcrasasmacro. Accessed September 10, 2014.
8. Elmore JG, Fletcher SW. The risk of cancer risk prediction: "What is my risk of getting breast cancer"? J Natl Cancer Inst. 2006;98(23):1673-1675.
9. Amir E, Freedman OC, Seruga B, et al. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst. 2010;102(10):680-691.
10. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886.
11. Baker LH. Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin. 1982;32(4):194-225.
12. Anderson GL, Manson J, Wallace R, et al. Implementation of the Women's Health Initiative study design. Ann Epidemiol. 2003;13(9):S5-S17.
13. Hays J, Hunt JR, Hubbell FA, et al. The Women's Health Initiative recruitment methods and results. Ann Epidemiol. 2003;13(9):S18-S77.
14. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health. 1997;6(1):49-62.
15. Chlebowski RT, Kuller LH, Prentice RL, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med. 2009;360(6):573-587.
16. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
17. Colditz GA, Martin P, Stampfer MJ, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol. 1986;123(5):894-900.
18. Justice AC, Covinsky KE, Berlin JA. Assessing the generalizability of prognostic information. Ann Intern Med. 1999;130(6):515-524.
19. Daly L. Simple SAS macros for the calculation of exact binomial and Poisson Confidence limits. Comput Biol Med. 1992;22(5):351-361.
20. Hosmer DW, Hosmer T, Le Cessie S, Lemeshow S. A comparison of goodness-of-fit tests for the logistic regression model. Stat Med. 1997;16(9):965-980.
21. Rosner B, Glynn RJ. Power and sample size estimation for the Wilcoxon rank sum test with application to comparisons of C statistics from alternative prediction models. Biometrics. 2009;65(1):188-197.
22. Schonfeld SJ, Pee D, Greenlee RT, et al. Effect of changing breast cancer incidence rates on the calibration of the Gail model. J Clin Oncol. 2010;28(14):2411-2417.
23. Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst. 1994;86(8):620-625.
24. Chlebowski RT, Anderson GL, Lane DS, et al. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. J Natl Cancer Inst. 2007;99(22):1695-1705.
25. Rohan TE, Negassa A, Chlebowski RT, et al. Conjugated equine estrogen and risk of benign proliferative breast disease: a randomized controlled trial. J Natl Cancer Inst. 2008;100(8):563-571.
26. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst. 1994;86(8):600-607.
27. Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001;93(5):358-366.
28. Schonberg MA, McCarthy EP, Davis RB, Phillips RS, Hamel MB. Breast cancer screening in women aged 80 and older: results from a national survey. J Am Geriatr Soc. 2004;52(10):1688-1695.
29. Cook NR, Rosner BA, Hankinson SE, et al. Mammographic screening and risk factors for breast cancer. Am J Epidemiol. 2009;170(11):1422-1432.
30. Schonberg MA, Marcantonio ER, Li D, et al. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol. 2010;28(12):2038-2045.
31. Chen J, Pee D, Ayyagari R et al. Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. J Natl Cancer Inst. 2006;98(17):1215-1225.